To evaluate the function of IBC in the paclitaxel resistance phenotypes of ERα+ breast cancer cells, we detected the protein expression of ERα and CD44 in paclitaxel‐resistant breast cancer cells with IBC treatment. The gene discussed is ESR1; the disease is breast carcinoma.